Key Points Curaleaf presented an unsolicited offer to buy Aurora Cannabis for $4 per share. Aurora rejected the offer, saying it didn't fully value Aurora's business. Curaleaf is now trying to stop Aurora from raising capital via stock sales. 10 stocks we like better than Aurora Cannabis › Curaleaf (OTC: CURLF) went public with an offer to buy marijuana competitor Aurora Cannabis (NASDAQ: ACB) in early Aug. 2026. Curaleaf stated that Aurora wasn't being responsive to private attempts to work out a deal. Aurora refuted those claims, and at this point, the relationship has only gone downhill. That's how hostile takeovers sometimes go. Here's what investors should watch as this one gets increasingly ugly.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.